HopeStage
Back to all studies
RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

Researchers are comparing ALTO-100 and placebo to find out how the approaches affect depression symptoms in adults with bipolarity during a depressive episode.

Medication studyAges 18–70United Kingdom + United States
The study in practice

Understand this study

What is this study about?

Researchers are comparing ALTO-100 and placebo to find out how the approaches affect depression symptoms in adults with bipolarity during a depressive episode.

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
Birmingham, United States · Chandler, United States and 58 more locationsSee all locations and recruitment
Activities
Medication described in the protocol · Placebo comparator
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 2, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
Alto Neuroscience
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom
Age range
From 18 Years to 70 Years
Official registry ID
NCT06656416
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Loading the security check...

You can withdraw your consent at any time. Your data and your rights

Recruitment & locations

Recruiting

Birmingham, United States · Chandler, United States · Phoenix, United States

57 more locations
  • Yuma, United States
  • Fayetteville, United States
  • Little Rock, United States
  • Chino, United States
  • Imperial, United States
  • Los Angeles, United States
  • Mather, United States
  • Oceanside, United States
  • Riverside, United States
  • Sacramento, United States
  • San Jose, United States
  • Colorado Springs, United States
  • Jacksonville, United States
  • Lauderhill, United States
  • Pinellas Park, United States
  • Tampa, United States
  • Atlanta, United States
  • Peachtree Corners, United States
  • Chicago, United States
  • Carmel, United States
  • West Lafayette, United States
  • Baltimore, United States
  • Bel Air, United States
  • Gaithersburg, United States
  • Towson, United States
  • Worcester, United States
  • Ann Arbor, United States
  • Grand Rapids, United States
  • Flowood, United States
  • Lincoln, United States
  • Las Vegas, United States
  • Toms River, United States
  • Albuquerque, United States
  • Amherst, United States
  • New York, United States
  • Cary, United States
  • Rose Hill, United States
  • Cincinnati, United States
  • North Canton, United States
  • Westlake, United States
  • Austin, United States
  • Beaumont, United States
  • Dallas, United States
  • Houston, United States
  • Plano, United States
  • Draper, United States
  • Fairfax, United States
  • Bellevue, United States
  • Derby, United Kingdom
  • Edinburgh, United Kingdom
  • Glasgow, United Kingdom
  • Liverpool, United Kingdom
  • London, United Kingdom
  • Newcastle upon Tyne, United Kingdom
  • Oxford, United Kingdom
  • Southampton, United Kingdom
  • York, United Kingdom

A listed location does not confirm current availability.

FAQ

Questions about this study

What is this study about?

Researchers are comparing ALTO-100 and placebo to find out how the approaches affect depression symptoms in adults with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is Alto Neuroscience.

Does this study involve medication?

Yes. The study involves medication, including ALTO-100 and Placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me